W
Walter M. Kirkendall
Researcher at University of Texas at Austin
Publications - 34
Citations - 1177
Walter M. Kirkendall is an academic researcher from University of Texas at Austin. The author has contributed to research in topics: Plasma renin activity & Blood pressure. The author has an hindex of 14, co-authored 34 publications receiving 1152 citations. Previous affiliations of Walter M. Kirkendall include University of Texas Health Science Center at Houston & Baylor College of Medicine.
Papers
More filters
Journal ArticleDOI
The Effect of Treatment on Mortality in Mild Hypertension: Results of the Hypertension Detection and Follow-up Program
Elbert Tuttle,Vickie Grimes,Aristide Apostolidcs,J. Richard Hebel,Albert Oberman,Harold W. Schnaper,James Kitts,Edward H. Kass,James O. Taylor,B. Frank Polk,Jeremiah Stamler,Rose Stamler,Flora C. Gosch,Davis Calif,Nemato Borhani,Marshall Lee,Beth Newman,Jack W. Jones,Sandra A. Daughcrty,Curtis G. Hames,Siegfried Heyden,H. A. Tyroler,Lawrence M. Slotkoff,Charles McCauley,Ro Lee,Herbert G. Langford,Myra Tyler,John D. Abernethy,Morton H. Maxwell,Andrew J. Lewin,Roger Detels,Reuben Berman,Ronald J. Prineas,Richard S. Crow,M. Donald Blaufox,Wassertheil Smoller Sylvia,Jeanne Hotchkiss,Hilmon Castle,Irving Ershler,Josephine Kastelet,Morton Hawkins,J. David Curb,Robert J. Hardy,Kenneth A. Schneider,Agostino Molteni,Edward Filzsimons,Wallace Williams,William J. Zukel,Gerald H. Payne,Alvin P. Shapiro,Glenn E. Bartsch,Kenneth G. Berge,Edward S. Cooper,Edward D. Frohlich,Richard H. Gadsden,David L. Sacken,Joseph A. Wilber,McFatc Smith,Walter M. Kirkendall,Curtis L. Meinert,Louis S. Monk,Richard D. Remington,Thomas P. Blaszkowski,Max Halperin,George Entwisle +64 more
TL;DR: The beneficial effect of stepped-care treatment on persons with diastolic pressures who had no evidence of end-organ damage and were not receiving antihypertensive medication when they entered the study is supported.
Journal ArticleDOI
A Comparison of the Efficacy and Safety of a β-Blocker, a Calcium Channel Blocker, and a Converting Enzyme Inhibitor in Hypertensive Blacks
Elijah Saunders,Matthew R. Weir,B. Wayne Kong,John W. Hollifield,James Gray,Victor Vertes,James R. Sowers,Michael B. Zemel,Charles L. Curry,James A. Schoenberger,Jackson T. Wright,Walter M. Kirkendall,Edward C. Conradi,Patricia Jenkins,Barry McLean,Barry M. Massie,Gerald S. Berenson,Walter Flamenbaum +17 more
TL;DR: Atenolol, captopril, and verapamil sustained release therapy was associated with goal blood pressure achievement during the first treatment period and during the second treatment period, and side effects were minimal and comparable for all three drugs.
Journal ArticleDOI
Persistence of Reduction in Blood Pressure and Mortality of Participants in the Hypertension Detection and Follow-up Program
Neil Shulman,Elbert Tuttle,George Entwisle,Aristide Apostolides,Albert Oberman,Harold W. Schnaper,Edward H. Kass,James O. Taylor,B. Frank Polk,Jeremiah Stamler,Rose Stamler,Flora C. Gosch,Nemat O. Borhani,Beth Newman,Linda C. Harlan,Marshall Lee,Jack W. Jones,Sandra A. Daugherty,H. A. Tyroler,Curtis G. Hames,Siegfried Heyden,Lawrence M. Slotkoff,Socrates Fotiu,Herbert G. Langford,John Abernathy,Myra Tyler,Morton H. Maxwell,Andrew Lewin,Roger Detels,Reuben Berman,Ronald J. Prineas,Richard S. Crow,M. Donald Blaufox,Sylvia Wassertheil-Smoller,C. Hilmon Castle,Josephine Kasteller,C. Morton Hawkins,Charles E. Ford,Barry R. Davis,Agostino Molteni,Kenneth A. Schneider,Edward J. Fitzsimmons,Gerald H. Payne,Thomas P. Blaszkowski,William J. Zukel,Alvin P. Shapiro,Glenn E. Bartsch,Kenneth G. Berge,Edward S. Cooper,Edward D. Frohlich,Richard H. Gadsden,David L. Sackett,Joseph A. Wilber,W. McFate Smith,Walter M. Kirkendall,Curtis L. Meinert,Louis S. Monk,Richard D. Remington,Max Halperin +58 more
TL;DR: The absolute mortality advantage found at 6.7 years persisted and increased throughout the posttrial period of follow-up despite discontinuation of the formal SC therapy program, postulated that regression of hypertensive end-organ changes brought about by the more effective SC treatment caused this favorable outcome.
Journal ArticleDOI
Treatment of hypertension in the elderly
TL;DR: Appropriate therapy for the elderly hypertensive must be individualized and should be associated with few or no side effects, and the thiazides are the preferred diuretics for long-term treatment of hypertension in the elderly.
Journal ArticleDOI
Prazosin and clonidine for moderately severe hypertension.
TL;DR: In a single-blind comparative study of the cases of 30 moderately hypertensive patients, clonidine hydrochloride and prazosin hydrochlorides had similar effectiveness in lowering blood pressure, and neither agent had significant effects on the renin-aldosterone axis.